Partnership will pursue cellular therapies for hard-to-treat wounds

04/9/2012 | Pharmaceutical Business Review Online

The human-based protein Elastatropin and technology involving adipose-derived stem cells and stromal cell culture media will be used to develop cellular treatments for wound healing and regenerative therapies. American CryoStem and Protein Genomics have formed a partnership that will focus on therapies for difficult-to-treat conditions.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN